Role of Ca2+/calmodulin-dependent phosphatase 2B in thrombin-induced endothelial cell contractile responses

Alexander Dmitriyevich Verin, Clare Cooke, Maria Herenyiova, Carolyn E. Patterson, Joe G N Garcia

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Thrombin-induced Ca2+ mobilization, activation of Ca2+/calmodulin- dependent myosin light chain (MLC) kinase (MLCK), and increased phosphorylation of MLCs precede and are critical to endothelial cell (EC) barrier dysfunction. Net MLC dephosphorylation after thrombin is nearly complete by 60 min and involves type 1 phosphatase (PPase 1) activity. We now report that thrombin does not alter total PPase 1 activity in EC homogenates but rather decreases myosin-associated PPase 1 activity. The PPase 1 inhibitor calyculin fails to prevent thrombin-induced MLC dephosphorylation. However, thrombin significantly increased the activity of Ca2+-dependent PPase 2B in EC homogenates (~1.5- to 2-fold), with PPase 2B activation correlating with phosphorylation of the PPase 2B catalytic subunit. Western immunoblotting revealed PPase 2B to be present in cytoskeletal EC fractions, with specific PPase 2B inhibitors such as cyclosporin (200 nM) and deltamethrin (100 nM to 1 μM) attenuating thrombin-induced cytoskeletal protein dephosphorylation, including EC MLC dephosphorylation. These results suggest a model whereby thrombin-inducible contraction is determined by the phosphorylation status of EC MLC regulated by the balance between EC MLCK, PPase 1 (constitutive), and PPase 2B (inducible) activities.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume275
Issue number4 19-4
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Calmodulin
Phosphoric Monoester Hydrolases
Thrombin
Endothelial Cells
Myosin Light Chains
Phosphorylation
Myosin-Light-Chain Kinase
Cytoskeletal Proteins
Myosins
Cyclosporine
Catalytic Domain
Phosphotransferases
Western Blotting

Keywords

  • Bovine pulmonary artery endothelium
  • Selective phosphatase 2B inhibitors
  • Thrombin-stimulated endothelial cell permeability
  • Thrombin-stimulated myosin light chain phosphorylation

ASJC Scopus subject areas

  • Cell Biology
  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)

Cite this

Role of Ca2+/calmodulin-dependent phosphatase 2B in thrombin-induced endothelial cell contractile responses. / Verin, Alexander Dmitriyevich; Cooke, Clare; Herenyiova, Maria; Patterson, Carolyn E.; Garcia, Joe G N.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 275, No. 4 19-4, 01.01.1998.

Research output: Contribution to journalArticle

@article{7ee4a11fc9354206afa520b47851d022,
title = "Role of Ca2+/calmodulin-dependent phosphatase 2B in thrombin-induced endothelial cell contractile responses",
abstract = "Thrombin-induced Ca2+ mobilization, activation of Ca2+/calmodulin- dependent myosin light chain (MLC) kinase (MLCK), and increased phosphorylation of MLCs precede and are critical to endothelial cell (EC) barrier dysfunction. Net MLC dephosphorylation after thrombin is nearly complete by 60 min and involves type 1 phosphatase (PPase 1) activity. We now report that thrombin does not alter total PPase 1 activity in EC homogenates but rather decreases myosin-associated PPase 1 activity. The PPase 1 inhibitor calyculin fails to prevent thrombin-induced MLC dephosphorylation. However, thrombin significantly increased the activity of Ca2+-dependent PPase 2B in EC homogenates (~1.5- to 2-fold), with PPase 2B activation correlating with phosphorylation of the PPase 2B catalytic subunit. Western immunoblotting revealed PPase 2B to be present in cytoskeletal EC fractions, with specific PPase 2B inhibitors such as cyclosporin (200 nM) and deltamethrin (100 nM to 1 μM) attenuating thrombin-induced cytoskeletal protein dephosphorylation, including EC MLC dephosphorylation. These results suggest a model whereby thrombin-inducible contraction is determined by the phosphorylation status of EC MLC regulated by the balance between EC MLCK, PPase 1 (constitutive), and PPase 2B (inducible) activities.",
keywords = "Bovine pulmonary artery endothelium, Selective phosphatase 2B inhibitors, Thrombin-stimulated endothelial cell permeability, Thrombin-stimulated myosin light chain phosphorylation",
author = "Verin, {Alexander Dmitriyevich} and Clare Cooke and Maria Herenyiova and Patterson, {Carolyn E.} and Garcia, {Joe G N}",
year = "1998",
month = "1",
day = "1",
language = "English (US)",
volume = "275",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4 19-4",

}

TY - JOUR

T1 - Role of Ca2+/calmodulin-dependent phosphatase 2B in thrombin-induced endothelial cell contractile responses

AU - Verin, Alexander Dmitriyevich

AU - Cooke, Clare

AU - Herenyiova, Maria

AU - Patterson, Carolyn E.

AU - Garcia, Joe G N

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Thrombin-induced Ca2+ mobilization, activation of Ca2+/calmodulin- dependent myosin light chain (MLC) kinase (MLCK), and increased phosphorylation of MLCs precede and are critical to endothelial cell (EC) barrier dysfunction. Net MLC dephosphorylation after thrombin is nearly complete by 60 min and involves type 1 phosphatase (PPase 1) activity. We now report that thrombin does not alter total PPase 1 activity in EC homogenates but rather decreases myosin-associated PPase 1 activity. The PPase 1 inhibitor calyculin fails to prevent thrombin-induced MLC dephosphorylation. However, thrombin significantly increased the activity of Ca2+-dependent PPase 2B in EC homogenates (~1.5- to 2-fold), with PPase 2B activation correlating with phosphorylation of the PPase 2B catalytic subunit. Western immunoblotting revealed PPase 2B to be present in cytoskeletal EC fractions, with specific PPase 2B inhibitors such as cyclosporin (200 nM) and deltamethrin (100 nM to 1 μM) attenuating thrombin-induced cytoskeletal protein dephosphorylation, including EC MLC dephosphorylation. These results suggest a model whereby thrombin-inducible contraction is determined by the phosphorylation status of EC MLC regulated by the balance between EC MLCK, PPase 1 (constitutive), and PPase 2B (inducible) activities.

AB - Thrombin-induced Ca2+ mobilization, activation of Ca2+/calmodulin- dependent myosin light chain (MLC) kinase (MLCK), and increased phosphorylation of MLCs precede and are critical to endothelial cell (EC) barrier dysfunction. Net MLC dephosphorylation after thrombin is nearly complete by 60 min and involves type 1 phosphatase (PPase 1) activity. We now report that thrombin does not alter total PPase 1 activity in EC homogenates but rather decreases myosin-associated PPase 1 activity. The PPase 1 inhibitor calyculin fails to prevent thrombin-induced MLC dephosphorylation. However, thrombin significantly increased the activity of Ca2+-dependent PPase 2B in EC homogenates (~1.5- to 2-fold), with PPase 2B activation correlating with phosphorylation of the PPase 2B catalytic subunit. Western immunoblotting revealed PPase 2B to be present in cytoskeletal EC fractions, with specific PPase 2B inhibitors such as cyclosporin (200 nM) and deltamethrin (100 nM to 1 μM) attenuating thrombin-induced cytoskeletal protein dephosphorylation, including EC MLC dephosphorylation. These results suggest a model whereby thrombin-inducible contraction is determined by the phosphorylation status of EC MLC regulated by the balance between EC MLCK, PPase 1 (constitutive), and PPase 2B (inducible) activities.

KW - Bovine pulmonary artery endothelium

KW - Selective phosphatase 2B inhibitors

KW - Thrombin-stimulated endothelial cell permeability

KW - Thrombin-stimulated myosin light chain phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=0031722950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031722950&partnerID=8YFLogxK

M3 - Article

C2 - 9755112

AN - SCOPUS:0031722950

VL - 275

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 4 19-4

ER -